Tags

Type your tag names separated by a space and hit enter

Hepatitis C infection and nonalcoholic fatty liver disease.
Clin Liver Dis. 2008 Aug; 12(3):573-85, viii-ix.CL

Abstract

In hepatitis C virus (HCV) infection, significant hepatic steatosis or superimposed nonalcoholic steatohepatitis is associated with disease severity and poor response to antiviral therapy. Nonalcoholic fatty liver disease (NAFLD) and HCV are common causes of chronic liver disease in Western countries and are strongly linked to concurrent obesity, insulin resistance, and the metabolic syndrome. With the escalating prevalence of obesity in North America, insulin resistance and the metabolic syndrome are major public health problems that have a significant impact on morbidity and mortality associated with NAFLD and HCV. This article focuses on the current understanding of the interplay between host and viral factors that are involved in the interaction between NAFLD and HCV.

Authors+Show Affiliations

Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18625429

Citation

Cheung, Onpan, and Arun J. Sanyal. "Hepatitis C Infection and Nonalcoholic Fatty Liver Disease." Clinics in Liver Disease, vol. 12, no. 3, 2008, pp. 573-85, viii-ix.
Cheung O, Sanyal AJ. Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis. 2008;12(3):573-85, viii-ix.
Cheung, O., & Sanyal, A. J. (2008). Hepatitis C infection and nonalcoholic fatty liver disease. Clinics in Liver Disease, 12(3), 573-85, viii-ix. https://doi.org/10.1016/j.cld.2008.03.005
Cheung O, Sanyal AJ. Hepatitis C Infection and Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2008;12(3):573-85, viii-ix. PubMed PMID: 18625429.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hepatitis C infection and nonalcoholic fatty liver disease. AU - Cheung,Onpan, AU - Sanyal,Arun J, PY - 2008/7/16/pubmed PY - 2008/9/20/medline PY - 2008/7/16/entrez SP - 573-85, viii-ix JF - Clinics in liver disease JO - Clin Liver Dis VL - 12 IS - 3 N2 - In hepatitis C virus (HCV) infection, significant hepatic steatosis or superimposed nonalcoholic steatohepatitis is associated with disease severity and poor response to antiviral therapy. Nonalcoholic fatty liver disease (NAFLD) and HCV are common causes of chronic liver disease in Western countries and are strongly linked to concurrent obesity, insulin resistance, and the metabolic syndrome. With the escalating prevalence of obesity in North America, insulin resistance and the metabolic syndrome are major public health problems that have a significant impact on morbidity and mortality associated with NAFLD and HCV. This article focuses on the current understanding of the interplay between host and viral factors that are involved in the interaction between NAFLD and HCV. SN - 1089-3261 UR - https://www.unboundmedicine.com/medline/citation/18625429/Hepatitis_C_infection_and_nonalcoholic_fatty_liver_disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1089-3261(08)00038-X DB - PRIME DP - Unbound Medicine ER -